As of Nov 19, 2026, 1 of 2 active firms rate VMD a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
VMD EPS & revenue forecast
EPS · NEXT QUARTER
$0.09
Range $0.07 – $0.12 · 3 analysts · +56% YoY
Next period, 3 analysts expect Viemed Healthcare Inc to earn $0.09 a share (range $0.07 – $0.12), versus $0.06 a year earlier. Full-year consensus is $0.40, growing to $0.52 the year after.
REVENUE · NEXT QUARTER
$82.6M
Range $81.8M – $83.6M · 3 analysts · +10% YoY
Revenue is expected to reach $82.6M (range $81.8M – $83.6M), +9.6% year-over-year. Full-year consensus is $317.9M, rising to $349.5M next year.
Top analysts covering Viemed Healthcare Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on VMD.
#1
IZ
Ilya Zubkov
Freedom Broker
Neutral
$11.00+25.1% to target
Coverage
—
+ Follow
#2
IZ
Ilya Zubkov
Freedom Capital Markets
Neutral
$11.00+25.1% to target
Coverage
—
+ Follow
VMD stock forecast FAQ
What is VMD's average 12-month price target?+
The 2 active firms with a live target average $12.50 for Viemed Healthcare Inc over the next 12 months, ranging from a $14.00 high to a $11.00 low, as of Nov 19, 2026.
Is VMD stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for VMD?+
The Street-high target is $14.00, and the Street-low is $11.00 (Freedom Broker). The average of all 2 active-firm targets is $12.50.
How many active Wall Street firms cover VMD?+
2 active firms have a recognized rating on Viemed Healthcare Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering VMD?+
Among analysts who currently cover VMD, Ilya Zubkov of Freedom Broker has the strongest overall Quantellect track record. Their current call is Neutral with a $11.00 target.
What is Viemed Healthcare Inc's projected EPS for next quarter?+
The consensus estimate is $0.09 per share (range $0.07 – $0.12) across 3 analysts. Full-year EPS is projected at $0.40, rising to $0.52 the following year.
How much revenue is Viemed Healthcare Inc expected to report next quarter?+
Consensus revenue is $82.6M (range $81.8M – $83.6M). Full-year revenue is projected at $317.9M, growing to $349.5M next year.
Have analysts been upgrading or downgrading VMD lately?+
As of Nov 19, 2026, 1 of 2 active firms rate VMD a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their VMD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.